Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 APOE genotype and cerebral blood flow in healthy young individuals.

Literature DB >> 14506116

APOE genotype and cerebral blood flow in healthy young individuals.

Nikolaos Scarmeas, Christian G Habeck, Yaakov Stern, Karen E Anderson.

Abstract

Entities: Gene

Mesh：

Substances：
Apolipoproteins E

Year: 2003 PMID： 14506116 PMCID： PMC3026566 DOI： 10.1001/jama.290.12.1581

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

× No keyword cloud information.

6 in total

1. Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain.

Authors: M Morishima-Kawashima; N Oshima; H Ogata; H Yamaguchi; M Yoshimura; S Sugihara; Y Ihara
Journal: Am J Pathol Date: 2000-12 Impact factor: 4.307

2. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele.

Authors: T Arendt; C Schindler; M K Brückner; K Eschrich; V Bigl; D Zedlick; L Marcova
Journal: J Neurosci Date: 1997-01-15 Impact factor: 6.167

3. Patterns of brain activation in people at risk for Alzheimer's disease.

Authors: S Y Bookheimer; M H Strojwas; M S Cohen; A M Saunders; M A Pericak-Vance; J C Mazziotta; G W Small
Journal: N Engl J Med Date: 2000-08-17 Impact factor: 91.245

4. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

Authors: E M Reiman; R J Caselli; L S Yun; K Chen; D Bandy; S Minoshima; S N Thibodeau; D Osborne
Journal: N Engl J Med Date: 1996-03-21 Impact factor: 91.245

5. High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes.

Authors: E Ghebremedhin; C Schultz; E Braak; H Braak
Journal: Exp Neurol Date: 1998-09 Impact factor: 5.330

6. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.

Authors: G W Small; J C Mazziotta; M T Collins; L R Baxter; M E Phelps; M A Mandelkern; A Kaplan; A La Rue; C F Adamson; L Chang
Journal: JAMA Date: 1995 Mar 22-29 Impact factor: 56.272

6 in total

21 in total

Review 1. Staging Alzheimer's disease progression with multimodality neuroimaging.

Authors: Michael Ewers; Giovanni B Frisoni; Stefan J Teipel; Lea T Grinberg; Edson Amaro; Helmut Heinsen; Paul M Thompson; Harald Hampel
Journal: Prog Neurobiol Date: 2011-06-22 Impact factor: 11.685

2. Higher cardiovascular fitness level is associated with lower cerebrovascular reactivity and perfusion in healthy older adults.

Authors: Brittany Intzandt; Dalia Sabra; Catherine Foster; Laurence Desjardins-Crépeau; Richard D Hoge; Christopher J Steele; Louis Bherer; Claudine J Gauthier
Journal: J Cereb Blood Flow Metab Date: 2019-07-25 Impact factor: 6.200

3. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Authors: Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski
Journal: Lancet Neurol Date: 2013-02 Impact factor: 44.182

10. Modulating effect of apolipoprotein E polymorphisms on secondary brain insult and outcome after childhood brain trauma.

Authors: T Y M Lo; P A Jones; I R Chambers; T F Beattie; R Forsyth; A D Mendelow; R A Minns
Journal: Childs Nerv Syst Date: 2008-10-07 Impact factor: 1.475

APOE genotype and cerebral blood flow in healthy young individuals.

1. Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain.

2. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele.

3. Patterns of brain activation in people at risk for Alzheimer's disease.

4. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

5. High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes.

6. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.

Review 1. Staging Alzheimer's disease progression with multimodality neuroimaging.

2. Higher cardiovascular fitness level is associated with lower cerebrovascular reactivity and perfusion in healthy older adults.

3. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Review 4. Biomarker modelling of early molecular changes in Alzheimer's disease.

5. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Review 6. APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.

Review 7. Imaging, subjective complaints, and MCI: 30 years before.

Review 8. Imaging studies and APOE genotype in persons at risk for Alzheimer's disease.

9. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.

10. Modulating effect of apolipoprotein E polymorphisms on secondary brain insult and outcome after childhood brain trauma.